文献速递泌尿生殖MR

基于MRI的深度学习算法辅助检测临床显著性前列腺癌:一项双中心前瞻性研究

MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study.
PubMed 文献 · Radiology · 2025-01-01

这项双中心前瞻性研究纳入205例疑似前列腺癌男性共259个病灶,以活检病理为参考标准,比较商业深度学习算法与放射科医生报告对临床显著性前列腺癌的检测效能。算法敏感度较低(80% vs 93%)但阳性预测值较高(58% vs 48%);在医生判读不确定时结合算法结果可将特异度从21%提高至44%,敏感度保持相似。

要点

  • 算法基于双参数MRI,敏感度低于放射科医生(80% vs 93%),但阳性预测值更高(58% vs 48%)。
  • 在医生PI-RADS 3分不确定时结合算法评分,特异度由21%升至44%,敏感度保持相似。
  • 算法与医生PI-RADS评分的AUC无显著差异(0.79 vs 0.77)。

核心结论

  • 在活检背景下,深度学习算法检测临床显著性前列腺癌的敏感度低于放射科医生,但阳性预测值更高;在放射科医生判读不确定时使用算法结果可能提高特异度并保持敏感度。

研究设计与样本

  • 前瞻性双中心研究,2022年12月至2023年7月纳入205例疑似前列腺癌男性共259个病灶,以活检病理为参考标准,比较商业深度学习算法(双参数MRI)与放射科医生(全部序列)的PI-RADS分类。

诊断标准与关键数值

  • 临床显著性前列腺癌定义为Gleason分级分组≥2;对放射科医生或算法判定PI-RADS≥3分的病灶行靶向前列腺活检。

临床应用与阅片要点

  • 算法检测临床显著性前列腺癌的敏感度为80%(94/117),放射科医生为93%(109/117),P=0.02;算法阳性预测值为58%(94/163),放射科医生为48%(109/227),P=0.008。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Although artificial intelligence is actively being developed for prostate MRI, few studies have prospectively validated these tools. Purpose To compare the diagnostic performance of a commercial deep learning algorithm (DLA) and radiologists' clinical reports for cancer detection in participants from two hospitals using histopathologic findings from biopsy specimens as the reference standard. Materials and Methods This prospective bicenter study enrolled participants suspected of having prostate cancer (PCa) who were scheduled for biopsy based on clinical information, including prostate MRI, from December 2022 to July 2023. Targeted prostate biopsies were performed for lesions with Prostate Imaging Reporting and Data System (PI-RADS) scores of 3 or higher, identified by either radiologists or the DLA. PI-RADS classifications by radiologists (using all imaging sequences), the DLA (using biparametric MRI), and the scenario in which radiologist-based PI-RADS 3 scores were modulated with DLA-based PI-RADS scores were compared using the area under the receiver operating characteristic curve (AUC) with DeLong and McNemar tests. Results A total of 259 lesions, including 117 clinically significant PCas (csPCas) (Gleason grade group ≥2), were evaluated in 205 men (median age, 68 years; age range, 47-90 years). At per-lesion analysis, the DLA had a lower sensitivity (94 of 117; 80%) and higher positive predictive value (PPV) (94 of 163; 58%) for detecting csPCa than did the radiologists (109 of 117 [93%] and 109 of 227 [48%]; P = .02 and P = .008, respectively). At per-participant analysis, incorporation of the DLA increased specificity from 23 of 108 (21%) to 48 of 108 (44%) (P = .001), with similar sensitivity (96 of 97 [99%] vs 93 of 97 [96%]; P = .74). There was no evidence of a difference in the AUC between radiologist-based and DLA-based PI-RADS score (0.77 [95% CI: 0.70, 0.82] vs 0.79 [95% CI: 0.73, 0.85]; P = .73). Conclusion The DLA demonstrated lower sensitivity but a greater PPV than radiologists for detecting csPCa in a biopsy setting. Using DLA results when radiologists' interpretations are indeterminate could improve specificity while maintaining sensitivity. International Clinical Trials Registry Platform registration no. KCT0006947 © RSNA, 2025 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Lee YJ, Moon HW, Choi MH, et al. MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study. Radiology. 2025. PMID: 40067105. doi:10.1148/radiol.232788

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。